Portal de Periódicos da CAPES

Pseudophakic cystoid macular edema: update 2016

2016; Dove Medical Press; Volume: Volume 11; Linguagem: Inglês

10.2147/cia.s111761

1178-1998

Andrzej Grzybowski, Bartosz L. Sikorski, Francisco J. Ascaso, Valentín Huerva,

Ocular Diseases and Behçet’s Syndrome

Abstract: Pseudophakic cystoid macular edema (PCME) is the most common complication of cataract surgery, leading in some cases to a decrease in vision. Although the pathogenesis of PCME is not completely understood, the contribution of postsurgical inflammation is generally accepted. Consequently, anti-inflammatory medicines, including steroids and nonsteroidal anti-inflammatory drugs, have been postulated as having a role in both the prophylaxis and treatment of PCME. However, the lack of a uniformly accepted PCME definition, conflicting data on some risk factors, and the scarcity of studies comparing the role of nonsteroidal anti-inflammatory drugs to steroids in PCME prevention make the problem of PCME one of the puzzles of ophthalmology. This paper presents an updated review on the pathogenesis, risk factors, and use of anti-inflammatory drugs in PCME that reflect current research and practice. Keywords: Pseudophakic cystoid macular edema, cataract surgery, cataract surgery complications, retina, post-operative complications